Archives

by in
Entry Author Date Location
XBiotech Takes Aim at Inflammation That Weakens Cancer Patients 05/17/13 Texas
Sialix Moves into SD’s Janssen Labs to Focus on Inflammatory Target 01/03/13 San Diego
SD Biotech Roundup: Life Technologies, KFx Medical, Shire, & More 06/15/12 San Diego
What Are the Hottest Targets in Biotech Today? 04/23/12 National
San Diego’s InflammaGen Advances Therapy to Mitigate Effects of Shock 03/12/12 San Diego
A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine 12/23/11 San Diego
Epizyme Takes $6M Upfront in Cancer Drug Deal with Eisai 03/10/11 Boston
San Diego’s Leading Ventures Takes on Commercialization of Bioengineering Breakthroughs 02/08/11 San Diego
Xoma Nabs $35M Upfront Deal 01/04/11 San Francisco
Anthera, On a Lean Budget, Seeks to Tap Big Heart Attack Market By Blocking Inflammation 11/16/10 San Francisco
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs 08/24/10 Boston
Alder Reduces Anemia in Cancer Study 06/06/10 Seattle
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma 06/02/10 Boston
How Internet Pioneer Larry Smarr Lost 20 Pounds by Becoming a “Quantified Self” 05/12/10 San Diego
Accelerator’s MicroRNA Play, Mirina, Forges Ahead With One More Year of Cash 04/26/10 Seattle
Genzyme Expects to Pay $175M to FDA, Westphal Leaves Sirtris to Run GSK Venture Arm, Gelesis Obesity Treatment Passes First Human Trial, & More Boston-Area Life Sciences News 04/23/10 Boston
Catabasis, Led by Sirtris Vets, Seeks to Fight Diabetes by Controlling Inflammation 04/21/10 Boston
Ascent Changes to Anchor 03/30/10 Boston
Flexion Snags Pfizer Bucks, Three Pharma Deals, For New Drug Model 01/29/10 Boston
Omeros Moves Closer To IPO, Sets Price Goal 09/16/09 Seattle
Lankau New CEO at Logical 05/11/09 Boston
Pfizer’s VC Leader, Barbara Dalton, on Corporate Venture and Northwest Deal Hunting 03/17/09 Seattle
Calistoga Reunites Icos Execs To Pursue Cancer, Inflammation Drugs 03/11/09 Seattle
Meritage Starts Study of Inflammatory Disease 01/22/09 San Diego
Qwell Pharmaceuticals, Backed by Arch, Raises $7M for New Cancer, Inflammation Drugs 01/06/09 Seattle
Another Next-Generation RNAi Startup Emerges, Makes Big Claims About Its Ability to Silence Bad Genes 12/18/08 Boston
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge 08/14/08 Boston
Novo Nordisk Returning to Seattle, Hiring 80 People by 2010 08/05/08 Seattle
Page 1 of 1